PharmiWeb12h
Septoplasty or Rhinoplasty? New Jersey Facial Plastic Surgeon Breaks Down the Difference
Dr. Anni Wong explains functional and aesthetic nasal corrections. FREEHOLD, NEW JERSEY / ACCESSWIRE / January 7, 2025 / In ...
PharmiWeb15h
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
PharmiWeb14h
Adnexus Biotechnologies Inc. Unveils AI-Driven Malaria Cure with Trapicolast
Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...
PharmiWeb4h
Lifeloc Technologies Secures $750,000 Financing to Support Growth and Innovation
WHEAT RIDGE, CO / ACCESSWIRE / January 7, 2025 / Lifeloc Technologies, Inc. (OTC PINK:LCTC), a leading provider of portable breath alcohol testing devices and related solutions, today announced the ...
PharmiWeb6h
Dr. Airica Steed Shares Vision for Transforming Healthcare on the American Journal of Healthcare Strategy Podcast
Dr. Airica Steed Shares Vision for Transforming Healthcare on the American Journal of Healthcare Strategy Podcast CLEVELAND, OH / ACCESSWIRE / January 7, 2025 / The healthcare landscape is undergoing ...
PharmiWeb6h
Laxxon Medical to Participate in 27th Annual Needham Growth Conference
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, today announced that management is ...
PharmiWeb12h
4SC announces update relating to Resminostat’s (Kinselby) Marketing Authorisation Application
SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage cutaneous T-cell lymphoma (CTCL), today announced that it had submitted its ...
PharmiWeb10h
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications ...
PharmiWeb11h
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules
Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indicationsNEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros ...
PharmiWeb9h
ProteinQure Strengthens Leadership Team with Key Appointments to Accelerate Translational and Clinical Development Programs
TORONTO, ON / ACCESSWIRE / January 7, 2025 / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two distinguished leaders to its team. Dr. Dave Garman has been ...
PharmiWeb12h
Neuraxpharm to further grow branded business with…
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...
PharmiWeb12h
Novartis gene therapy poised to expand SMA treatment landscape, says GlobalData
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...